Prof. Carolyn Bertozzi gave the Caspi Lecture in Chemical Biology at UMass Medical School on September 19, 2017.
The talk, entitled, “Cancer immune therapies targeting glyco-immune checkpoints” was inspiring and discussed her latest research to develop novel immunooncology therapeutics that target abnormal glycosylation patterns and receptors.
Prof. Bertozzi is the Anne T. and Robert M. Bass Professor of Chemistry and Chemical & Systems Biology at Stanford University, and an Investigator of the Howard Hughes Medical Institute. She completed her undergraduate degree in Chemistry from Harvard University in 1988 and her Ph.D. in Chemistry from UC Berkeley in 1993. After completing postdoctoral work at UCSF in the field of cellular immunology, she joined the UC Berkeley faculty in 1996. In June 2015, she joined the faculty at Stanford University, coincident with the launch of Stanford’s Chemistry, Engineering & Medicine for Human Health (ChEM-H) institute.
The Caspi Lecture is named after Eliahu Caspi, an internationally renowned steroid chemist at the Worcester Foundation which merged with UMass Medical School in 1997. Dr. Caspi was the author of more than 300 publications and was the recipient of many awards including the Walter Pincus Medal in steroid biochemistry in 1994.